John Vandermosten
LightNews LightNews
vanjohn10.bsky.social
John Vandermosten
@vanjohn10.bsky.social
27 followers 13 following 480 posts
Life Sciences, Analyst, Media Operations, Investor Awareness
Owner of Unboxing Biotech, a channel that features life sciences executives and their companies.
Posts Replies Media Videos
vanjohn10.bsky.social
Dr. Ann Childress, principal investigator on Cingulate’s CTx-1301 trials, highlights some of the differences in ADHD symptoms between children and adults.
#ADHD #Neuroscience #Biotech #SmallCapBiotech #BiotechInvesting #ClinicalPipeline #DrugDevelopment #NASDAQ
October 27, 2025 at 3:13 PM
vanjohn10.bsky.social
Reviva Pharmaceuticals' #CEO Laxminarayan Bhat, Ph.D. shares examples of positive and negative symptoms in schizophrenia. #FDA
$RVPH
#schizophrenia #biopharma #biotech
October 23, 2025 at 1:43 PM
vanjohn10.bsky.social
Dr Ann Childress, principal investigator on #Cingulate CTx-1301 trials, comments on an article that finds an association between use of ADHD medication and lower suicide risk.
$CING
www.bmj.com/content/390/...
#ADHD #Biotech #DrugDevelopment #ADHDTreatment #NASDAQ
October 22, 2025 at 4:26 PM
vanjohn10.bsky.social
Dr. Ann Childress, principal investigator on Cingulate's CTx-1301 trials, shares a story about ADHD medications that only work for part of the day.
$CING
#Cingulate #ADHD #Neuroscience #Biotech #BiotechStocks #LifeSciences #NASDAQ
October 20, 2025 at 7:08 PM
vanjohn10.bsky.social
Dr. Ann Childress describes how the new #ADHD medication CTx-1301 works in this brief clip.
$CING
#Cingulate #Biotech #ClinicalTrials #LifeSciences #ADHDResearch #BiotechInvesting #PharmaNews #NASDAQ
October 18, 2025 at 4:32 PM
vanjohn10.bsky.social
Chief Commercial Officer Jaime Xinos explains Achieve Life Sciences’ strategy to deploy digital resources for maximum effect.
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences #PublicHealth #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
October 13, 2025 at 12:49 PM
vanjohn10.bsky.social
Reviva Pharmaceuticals' #CEO Dr Bhat elaborates on brilaroxazine’s sustained efficacy and low discontinuation rate.
#schizophrenia #biopharma #biotech
October 12, 2025 at 11:02 AM
vanjohn10.bsky.social
Achieve Life Sciences’ CEO Rick Stewart identifies varenicline side effects that may have led to discontinuation and compares with cytisinicline.
$ACHV
#SmokingCessation #ClinicalTrials #LifeSciences #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
October 11, 2025 at 2:06 PM
vanjohn10.bsky.social
Lexaria Bioscience CEO Richard Christopher summarizes details from $LEXX human clinical trials evaluating #DehydraTECH & GLP1 agonists along with the technology’s key benefits.
#LexariaBioscience #LexariaDelivery #NextGenDrugDelivery #OralDeliveryTech #OralPeptideDelivery #GLP1Therapy #GLP1Agonist
October 6, 2025 at 8:27 PM
vanjohn10.bsky.social
Founder & CEO Bernard Peperstraete explains how Acuamark Diagnostics uses the qPCR technology & modifies it for better performance in cancer detection.
#methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare #MedicalTesting #DiagnosticServices #LabServices
September 29, 2025 at 8:52 PM
vanjohn10.bsky.social
Founder & CEO Bernard Peperstraete provides the context behind Acuamark Diagnostics' anticipated capital raise, outlines related milestones and plans additional studies to further characterize the cancer diagnostic.
#methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare
September 26, 2025 at 10:30 PM
vanjohn10.bsky.social
Achieve Life Sciences’ #CEO Rick Stewart shares a success with its development of cytisinicline.
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences
September 25, 2025 at 2:15 PM
vanjohn10.bsky.social
GeoVax CEO David Dodd shares his management philosophy in the face of substantial change in the healthcare environment.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #InnovativeMedicine #Biotech #TargetedTherapy #Immunotherapy #OrphanDrug #ClinicalTrials #CancerTreatment
September 24, 2025 at 1:26 PM
vanjohn10.bsky.social
Founder & CEO Bernard Peperstraete explains the role of quantitative polymerase chain reaction (qPCR) and how Acuamark is using it for diagnostic testing in cancer.
#methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare #MedicalTesting #MedTech #Laboratory
September 22, 2025 at 4:04 PM
vanjohn10.bsky.social
GeoVax’ greater productivity of its MVA vaccine platform supports its use in the United States and developing regions. CEO David Dodd explains.
$GOVX
#biotech #biotechnology #science #vaccine
September 19, 2025 at 2:35 PM
vanjohn10.bsky.social
#ICYMI, Spectral AI founder & chairman Dr J Michael DiMaio walks us through the regulatory milestones we should expect as DeepView traverses the De Novo regulatory approval process.
$MDAI
#SpectralAI #WoundCare #MedicalAI #AI #HealthTech #MedTech #LifeSciences #Biotech #MedicalDevices
September 19, 2025 at 1:58 PM
vanjohn10.bsky.social
Acuamark's Founder & CEO Bernard Peperstraete responds to John’s question about M&A in the cancer diagnostic space.
#methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare #MedicalTesting #DiagnosticServices #MedTech #HealthTech #Laboratory
September 16, 2025 at 8:31 AM
vanjohn10.bsky.social
Bavarian Nordic deal highlights M&A. Join CEO David Dodd who discusses the implications for @Geovax_News.
$GOVX
#biotech #biotechnology #science #Gedeptin #Biotech #ClinicalTrials #CancerTreatment
September 15, 2025 at 7:41 AM
vanjohn10.bsky.social
Acuamark's Founder & CEO Bernard Peperstraete discusses the upcoming Series B round, what it will fund and the milestones associated with it.
#methylation #Diagnostics #MedTech #HealthTech #Laboratory
September 13, 2025 at 2:40 PM
vanjohn10.bsky.social
FORCE Family Office invited us to speak with Acuamark Diagnostics, Inc's CEO Bernard Peperstraete. In this clip he compares the relative accuracy rates of other cancer diagnostics compared to Acuamark’s test.
#methylation #Diagnostics #MedTech
September 12, 2025 at 6:24 PM
vanjohn10.bsky.social
We've all heard about monoclonal antibodies, vaccines and recombinant proteins, but where do they come from? Join @Dyadic’s COO Joe Hazelton as he introduces C1 and its capabilities.
$DYAI
#Biotech #Vaccines #LifeSciences
September 12, 2025 at 5:36 PM
vanjohn10.bsky.social
FORCE Family Office invited us to speak with Acuamark Diagnostics's CEO Bernard Peperstraete to learn about the technology & marker behind the company's diagnostic cancer test.
#methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare
September 8, 2025 at 5:43 PM
vanjohn10.bsky.social
#ICYMI, Spectral AI founder & chairman Dr J Michael DiMaio explains what to expect after #FDA DeepView clearance.
$MDAI
September 8, 2025 at 2:48 PM
vanjohn10.bsky.social
CEO David Dodd shares GeoVax' strategy for generating value driven by clinical development milestones.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #Oncology #InnovativeMedicine #Biotech #TargetedTherapy #Immunotherapy #OrphanDrug #ClinicalTrials #CancerTreatment
September 6, 2025 at 6:27 PM
vanjohn10.bsky.social
What's the source of Dyadic's future revenues? $DYAI COO Joe Hazelton explains how the company's partnerships will generate topline contributions from non-therapeutic proteins, cell & gene therapy media & bio-industrial applications.
#Biotech #Biotechnology #LifeSciences #ProteinTherapeutics
September 6, 2025 at 5:48 PM